Category: Import and Export

Home>>CBPMImport and ExportMHRAAssociates

Since the approval for specialist prescribers to write scripts for CBPMs (Cannabis based medicinal products) was given for 01 Nov 2019, there has been a flurry of activity to get licensed. Paradigm Shift have had multiple enquiries about licensing for the procurement and supply of CBPMs, and are working with a number of companies in…

Many wholesalers have been found to be deficient during their GDP MHRA inspections, especially with their Chapter 30 Commodity codes, when exporting pharmaceutical products. Many have exported pharmaceutical products either using a “blanket” code that they believe suits finished products, or in some cases not even coding their products at all. In some circles the…

Import tax minimisation and planning Import taxes include customs duty and VAT and these represent high costs within international supply chains. They impact EU manufacturers and distributors that source raw materials or finished products from overseas. Even UK/EU suppliers can also be a source of opportunity, should they have previously imported products that are being…

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close